CalciMedica is trading at $0.78 (+5.9%) in after-hours sessions, rebounding from a sharp drop on Thursday despite a lack of company-specific news.

  • The move appears to be a light-liquidity bounce and price-action follow-through following a volatile week for the stock.
  • No new SEC filings, press releases, or analyst updates were issued on July 17, 2026, to explain the upward momentum.
  • The gain comes against a backdrop of broader market weakness across major indices.